Team Structure headcount by department
How to prospect Daiichi Sankyo Oncology France's departments
Other
With 5 people, this is the organisation's biggest team. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.
Medical
The company's second-largest department (4 people). Medical teams trust peer references: name comparable organisations you already serve.
Finance
A team of 3 people. These decision makers arbitrate budgets: a well-quantified business case is your best door opener.
Research
This department counts 3 people. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.
General Management
2 people work in this department. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.
Project Management
A team of 1 people. Deadlines and cross-team coordination are the daily battle: position yourself on predictability and visibility.
FAQ Daiichi Sankyo Oncology France
Who runs Daiichi Sankyo Oncology France?
The highest-ranking leadership role identified at Daiichi Sankyo Oncology France is “Director, Data Management”, based on public data updated 11 Oct 2026.
How many decision makers does Daiichi Sankyo Oncology France have?
1 decision maker identified.
How do I contact a decision maker at Daiichi Sankyo Oncology France?
Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.
Companies similar to Daiichi Sankyo Oncology France
More companies to explore
Research Services · France
-
Saint-Gobain Research Provence 500 employees
-
Eurecom 500 employees
-
École Polytechnique 5,000 employees
Same group · daiichi-sankyo.fr
About Daiichi Sankyo Oncology France
Daiichi Sankyo Oncology France is a company active in the Research Services space, operating from France. Founded in 1899, the company has a workforce of roughly 5,000 people. As part of the broader Professional Services sector, Daiichi Sankyo Oncology France operates specifically in the Research Services segment. Daiichi Sankyo Oncology France sells primarily to other businesses (B2B) rather than to end consumers. The data below (industry, headcount, location and business signals) helps sales teams qualify Daiichi Sankyo Oncology France and pinpoint the right decision makers from the first touchpoint.
Activity & Market
The company evolves in the Research Services segment of the Professional Services sector. As a B2B company, Daiichi Sankyo Oncology France primarily serves business clients and professional organisations. In terms of structure, it is registered as “Self-owned”.